Piper Sandler downgraded Arhaus (ARHS) to Neutral from Overweight with a price target of $12, down from $15. Published first on TheFly – the ...

Fintel reports that on February 26, 2025, Piper Sandler upgraded their outlook for ZoomInfo Technologies (NasdaqGS:ZI) from ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Mary Stone as a ...

Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Fulcrum Therapeutics (FULC – Research Report), with a ...

In a report released today, Thomas Champion from Piper Sandler maintained a Buy rating on Maplebear (CART – Research Report), with a price ...